1 |
张薇,魏来. 非酒精性脂肪性肝病在亚洲的流行情况 [J]. 中华肝脏病杂志, 2013, 21(11): 801-804.
|
2 |
濮佳琦, 王森杰, 薛初晴, 等. 儿童脂肪性肝病命名探析 [J]. 中华儿科杂志, 2023, 61(2): 104-107.
|
3 |
Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement [J]. J Hepatol, 2020, 73(1): 202-209.
|
4 |
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases [J]. Hepatol, 2018, 67(1): 328-357.
|
5 |
中华医学会儿科学分会内分泌遗传代谢学组,中华医学会儿科学分会消化学组,中华医学会儿科学分会青春期医学专业委员会,等. 儿童非酒精性脂肪肝病诊断与治疗专家共识 [J]. 中国实用儿科杂志, 2018, 33(7): 487-492.
|
6 |
中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018年更新版) [J]. 临床肝胆病杂志, 2018, 34(5): 947-957.
|
7 |
van Werven JR, Marsman HA, Nederveen AJ, et al. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy[J]. Radiology, 2010, 256(1): 159-168.
|
8 |
中华医学会儿科学分会内分泌遗传代谢学组,中华医学会儿科学分会儿童保健学组, 中华医学会儿科学分会临床营养学组,等. 中国儿童肥胖诊断评估与管理专家共识 [J]. 中华儿科杂志, 2022, 60(6): 507-515.
|
9 |
Eslam M, Sarin SK, Wong VW, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease [J]. Hepatol Int, 2020, 14(6): 889-919.
|
10 |
Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest [J]. Hepatology, 2007, 46(1): 32-36.
|
11 |
Nan Y, An J, Bao J, et al. The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease [J]. J Hepatol, 2021, 75(2): 454-461.
|
12 |
Sarin SK, Kumar M, Eslam M, et al. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission [J]. Lancet Gastroenterol Hepatol, 2020, 5(2): 167-228.
|
13 |
Fang YL, Chen H, Wang CL, et al. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”[J]. World J Gastroenterol, 2018, 24(27): 2974-2983.
|
14 |
Kuroda H, Abe T, Fujiwara Y, et al. Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease [J]. J Med Ultrason (2001), 2021, 48(4): 471-480.
|
15 |
Fujiwara Y, Kuroda H, Abe T, et al. The B-mode image-guided ultrasound attenuation parameter accurately detects hepatic steatosis in chronic liver disease [J]. Ultrasound Med Biol, 2018, 44(11): 2223-2232.
|
16 |
Imajo K, Toyoda H, Yasuda S, et al. Utility of ultrasound-guided attenuation parameter for grading steatosis with reference to MRI-PDFF in a large cohort [J]. Clin Gastroenterol Hepatol, 2022, 20(11): 2533-2541.e7.
|
17 |
Yoon H, Kim J, Lim HJ, et al. Attenuation coefficient measurement using a high-frequency (2-9 MHz) convex transducer for children including fatty liver [J]. Ultrasound Med Biol, 2022, 48(6): 1070-1077.
|
18 |
Zhao Y, Jia M, Zhang C, et al. Reproducibility of ultrasound-guided attenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis [J]. Sci Rep, 2022, 12(1): 2876.
|
19 |
包静文,朱宇莉,徐庆玥,等. 超声声衰减成像评估代谢相关脂肪性肝病肝脂肪变程度的应用价值 [J]. 中华超声影像学杂志, 2021, 30(10): 868-873.
|
20 |
Iwashita H, Shakado S, Yoshimaru N, et al. Clinical utility of ultrasound-guided attenuation parameter for the detection and quantification of hepatic steatosis in patients with fatty liver diagnosed by computed tomography [J]. Ultrasound Med Biol, 2022, 48(7): 1282-1289.
|
21 |
张姝嫔,程成,祝怡婕,等. 超声衰减成像定量诊断非酒精性脂肪肝的应用价值初探讨 [J]. 中国超声医学杂志, 2021, 37(1): 66-69.
|
22 |
Stefan N, Schick F, Häring HU. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans [J]. Cell Metab, 2017, 26(2): 292-300.
|
23 |
Tada T, Kumada T, Toyoda H, et al. Liver stiffness does not affect ultrasound-guided attenuation coefficient measurement in the evaluation of hepatic steatosis [J]. Hepatol Res, 2020, 50(2): 190-198.
|